MTOR and cutaneous melanoma: A missense mutation in mTOR Q2499R was detected in both instances at 0.49 allele frequency for a high tumor content of 80%, and could represent a germline cancer predisposing variant rather than a somatic mutation in this relatively young patient with history of both cutaneous melanoma and glioblastoma (Figure 3D).